Text Size

Prostate Cancer Nomograms : Disclaimer

The prediction tools, also known as prognostic nomograms, located on the MSKCC Web site are for general health information only. The prediction tools are not to be used as a substitute for medical advice, diagnosis, or treatment of any health condition or problem.

Users of the prediction tools should not rely on information provided by the prediction tools for their own health problems. Questions should be addressed to your own physician or other healthcare provider.

MSKCC makes no warranties, nor express or implied representations whatsoever, regarding the accuracy, completeness, timeliness, comparative or controversial nature, or usefulness of any information contained or referenced in the prediction tools. MSKCC does not assume any risk whatsoever for your use of the prediction tools or the information contained herein. Health related information changes frequently and therefore information contained in the prediction tools may be outdated, incomplete or incorrect.

Use of the prediction tools does not create an express or implied physician-patient relationship. MSKCC does not endorse or claim validity for the prediction tools found on the MSKCC Web site. The activities and products of MSKCC and its developers and agents (collectively MSKCC) are not endorsed by our past, present, or future employers. MSKCC does not record specific prediction tool user information and does not contact users of the prediction tools.

You are hereby advised to consult with a physician or other professional healthcare provider prior to making any decisions, or undertaking any actions or not undertaking any actions related to any healthcare problem or issue you might have at any time, now or in the future. In using the prediction tools, you agree that neither MSKCC nor any other party is or will be liable or otherwise responsible for any decision made or any action taken or any action not taken due to your use of any information presented in the prediction tools.

I accept all of the above terms by clicking here or by any further use of this service.
I do not accept all of the above terms.

Prostate Cancer Nomograms: Salvage Radiation Therapy

This nomogram is designed for men who have experienced a recurrence of their prostate cancer after treatment with radical prostatectomy. The tool predicts the probability the recurrence can be successfully treated with salvage radiation therapy (SRT), calculating the probability that the cancer will be controlled and the PSA will be undetectable six years after SRT. To learn more, visit our frequently asked questions.

CalculateClearEnter Your Information

To gather the information required below, download our PDF worksheet.

PSA value before radical prostatectomy.
(0.1 to 100 ng/ml)

Gleason Grade

Primary Gleason grade from the radical prostatectomy pathology report.
Secondary Gleason grade from the radical prostatectomy pathology report.
Gleason Sum will be automatically calculated or can be added here if the primary and secondary Gleason grades are not known.

Prostatectomy Pathology Report Details

Was cancer present at edges of removed prostate?
Was there extra capsular extension?
Was cancer present in seminal vesicles?
Was cancer present in pelvic lymph nodes?
Did the PSA value obtained after radical prostatectomy remain elevated? (I.E. Did the PSA value never decrease to an undetectable level?)
PSA value from the most recent laboratory report or the value immediately before starting salvage radiation therapy.
(0.1 to 100 ng/ml)
The PSA doubling time should be calculated from all PSA values obtained over the last 12 months -- or all values following radical prostatectomy, beginning when the PSA reached its lowest level. To calculate PSA doubling time, visit the PSA Doubling Time calculator.
(0.001 to 10000 months)
Radiation dose value between 10 and 100 Gy. (1,000 rads = 10 Gys.)
(10 to 100 Gy)
Number of months after radical prostatectomy before PSA level was elevated to 0.2 or higher.
months
Does your radiation oncologist plan to administer hormone therapy before or along with the salvage radiation therapy?

Learn More About Your Results

Progression Free Probability after Salvage Radiation Therapy

For patients who were initially treated with radical prostatectomy, this nomogram predicts the probability that a patient’s prostate cancer will not progress at 6 years after salvage radiation therapy for PSA-defined recurrence.

Supporting Publication

Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol. 2007 May 20;25(15):2035-41. Erratum in: J Clin Oncol. 2007 Sep 10;25(26):4153.